These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6132804)

  • 21. [Can beta blockers prevent gastrointestinal bleeding from varices in cirrhotic patients?].
    Malè PJ
    Schweiz Rundsch Med Prax; 1984 Jun; 73(26):815-6. PubMed ID: 6147887
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study].
    Santambrogio R; Galeotti F; Opocher E; Cucchiaro G; Cornalba GP; Rota L; Ferrario M; Fumagalli U; Spina GP
    Minerva Med; 1986 Mar; 77(12):429-32. PubMed ID: 2871526
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary prevention of bleeding from esophageal varices.
    Burroughs AK; Patch D
    N Engl J Med; 1999 Apr; 340(13):1033-5. PubMed ID: 10099147
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study].
    Dollet JM; Champigneulle B; Patris A; Bigard MA; Gaucher P
    Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sclerotherapy for the prevention of bleeding esophageal varices].
    Paquet KJ
    Internist (Berl); 1983 Feb; 24(2):81-4. PubMed ID: 6341290
    [No Abstract]   [Full Text] [Related]  

  • 26. Oesophageal varices prior to bleeding. Diagnosis and physiological and therapeutic effects of propranolol in cirrhosis.
    Bendtsen F
    Dan Med Bull; 1993 Jun; 40(3):306-16. PubMed ID: 8339602
    [No Abstract]   [Full Text] [Related]  

  • 27. Bleeding from ruptured oesophageal varices: propranolol for primary prevention.
    Prescrire Int; 2012 Mar; 21(125):73-7. PubMed ID: 22428197
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of sclerosing therapy as a primary therapeutic measure in active hemorrhage from esophageal varices].
    Mora P; Suárez JM; Garza E; del Rey R; Segura JM; Martín J; Merino MJ; Muro J
    Rev Esp Enferm Apar Dig; 1988 Mar; 73(3):233-6. PubMed ID: 3285389
    [No Abstract]   [Full Text] [Related]  

  • 29. [Incidence and significance of bleeding from gastric varices in liver cirrhosis ,its diagnostic and therapeutic relevance].
    Kalk JF; Paquet KJ; Koussouris P
    Schweiz Rundsch Med Prax; 1984 Sep; 73(38):1149-50. PubMed ID: 6333708
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of the anesthetist during the preparation and surveillance of sclerosing of the esophageal varices in cirrhotic subjects presenting with a contra-indication for portacaval anastomosis].
    Greffe B; Charvoz J; Riche J; Bertrand M; Rollina-Levasseur AL; Pinel J; Guéry J
    Anesth Analg (Paris); 1976; 33(6):945-52. PubMed ID: 1088338
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic and prevention strategies of gastroesophageal varices and variceal hemorrhage in cirrhosis].
    Xu XY; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):252-3. PubMed ID: 19403019
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of recurrent hemorrhage due to portal hypertension].
    Lebrec D
    Schweiz Med Wochenschr; 1986 Apr; 116(17):552-4. PubMed ID: 3487112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sclerosing injections of bleeding oesophageal varices in inoperable patients (author's transl)].
    Kapp F; Buess HJ
    Dtsch Med Wochenschr; 1973 Dec; 98(52):2465-9. PubMed ID: 4543766
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary prevention of esophageal variceal rupture: endoscopic ligation or propranolol?].
    Oberti F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1104-6. PubMed ID: 10592890
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-blockers in prevention of variceal hemorrhage: tantalizing expectations.
    Selub S; Barkin JS
    Am J Gastroenterol; 1992 Feb; 87(2):253-5. PubMed ID: 1346479
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent situation in drug treatment for esophageal varices.
    Lebrec D
    Hepatogastroenterology; 1997; 44(15):615-9. PubMed ID: 9222661
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary prevention of variceal bleeding in cirrhosis].
    Schepke M
    Dtsch Med Wochenschr; 2006 Jun; 131(22):1269-72. PubMed ID: 16755423
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wedged hepatic vein pressure (WHVP): ready for prime time.
    Boyer TD
    Hepatology; 2006 Mar; 43(3):405-6. PubMed ID: 16496346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.